Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level

✍ Scribed by Katsuno, K.; Fujimori, Y.; Takemura, Y.; Hiratochi, M.; Itoh, F.; Komatsu, Y.; Fujikura, H.; Isaji, M.

• Book ID: 121820454
• Publisher: American Society for Pharmacology and Experimental Therapeutics
• Year: 2006
• Tongue: English
• Weight: 413 KB
• Volume: 320
• Category: Article
• ISSN: 0022-3565
• DOI: 10.1124/jpet.106.110296